Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 18 February 2014
Vol. 7, Issue 313, p. ra17
[DOI: 10.1126/scisignal.2004785]

RESEARCH ARTICLES

Editor's Summary

Negatively Adapting Metabolism
Deficiency of the adaptor protein p66Shc, which inhibits signaling through receptor tyrosine kinases, improves the glucose tolerance of mice that are a genetic model of obesity. Soliman et al. found that in both transformed and nontransformed cells, p66Shc silencing enhanced glucose metabolism, increased the abundance of intermediates in various biosynthetic pathways, and increased cell size. The change in metabolism required the mTOR pathway, which couples energy, nutrient, and growth factor (including insulin) signals to processes that mediate cellular growth and proliferation. Thus, p66Shc suppresses mTOR signaling, and manipulating the abundance of p66Shc or interfering with p66Shc function could be used to treat diseases characterized by disruptions in this pathway, including diabetes and cancer.

Citation: M. A. Soliman, A. M. Abdel Rahman, D. W. Lamming, K. Birsoy, J. Pawling, M. E. Frigolet, H. Lu, I. G. Fantus, A. Pasculescu, Y. Zheng, D. M. Sabatini, J. W. Dennis, T. Pawson, The Adaptor Protein p66Shc Inhibits mTOR-Dependent Anabolic Metabolism. Sci. Signal. 7, ra17 (2014).

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Science Signaling Podcast: 18 February 2014.
J. W. Dennis, M. A. Soliman, and A. M. VanHook (2014)
Science Signaling 7, pc6
   Abstract »    Full Text »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882